Sign in

CIK 0001035354

  • Non-accelerated filer
  • Smaller reporting company

Eloxx Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELOX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841368850
Phone
+1 781-577-5300
Business address
P.O. BOX 274, ARLINGTON, MA, 02476
Former names
Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market buy Director bought 2,466,666 shares at $1.35 ($3,329,999)
  4. 4 Open-market buy 10% owner bought 5,925,925 shares at $1.35 ($7,999,999)
  5. 4 Open-market buy Director bought 5,925,925 shares at $1.35 ($7,999,999)
  6. 4 Open-market buy Director bought 5,925,925 shares at $1.35 ($7,999,999)
  7. 4 Shares withheld for taxes COO, GENERAL COUNSEL &CORP SEC gave up 459 shares (to pay taxes)
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award Director acquired 2,532,270 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 4 Shares withheld for taxes COO, GENERAL COUNSEL &CORP SEC gave up 7,338 shares (to pay taxes)
  20. 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 15,360 shares (to pay taxes)

Page 4 of 29 · 574 filings